AML1 (CBFα2) Cooperates with B Cell-specific Activating Protein (BSAP/PAX5) in Activation of the B Cell-specific BLK Gene Promoter*

AML1 plays a critical role during hematopoiesis and chromosomal translocations involving AML1 are commonly associated with different forms of leukemia, including pre-B acute lymphoblastic leukemia. To understand the function of AML1 during B cell differentiation, we analyzed regulatory regions of B cell-specific genes for potential AML1-binding sites and have identified a putative AML1-binding site in the promoter of the B cell-specific tyrosine kinase gene, blk. Gel mobility shift assays and transient transfection assays demonstrate that AML1 binds specifically to this site in the blk promoter and this binding site is important for blk promoter activity. Furthermore, in vitro binding analysis revealed that the AML1 runt DNA-binding domain physically interacts with the paired DNA-binding domain of BSAP, a B cell-specific transcription factor. BSAP has been shown previously to be important for B cell-specific regulation of the blkgene. Physical interaction of AML1 with BSAP correlates with functional cooperativity in transfection studies where AML1 and BSAP synergistically activate blk promoter transcription by more than 50-fold. These results demonstrate physical and functional interactions between AML1 and BSAP and suggest that AML1 is an important factor for regulating a critical B cell-specific gene,blk.

[1]  P. Zwollo,et al.  The Transcription Factor NF-κB/p50 Interacts with the blkGene during B Cell Activation* , 1998, The Journal of Biological Chemistry.

[2]  D. Tenen,et al.  Multiple Functional Domains of AML1: PU.1 and C/EBPα Synergize with Different Regions of AML1 , 1998, Molecular and Cellular Biology.

[3]  H. Dintzis,et al.  Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  N. Speck,et al.  ETS-Core Binding Factor: a Common Composite Motif in Antigen Receptor Gene Enhancers , 1998, Molecular and Cellular Biology.

[5]  J. Downing,et al.  The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation , 1998, Molecular and Cellular Biology.

[6]  A. Friedman,et al.  Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb , 1997, Molecular and cellular biology.

[7]  J. Licht,et al.  Transcription factors, normal myeloid development, and leukemia. , 1997, Blood.

[8]  M. Busslinger,et al.  Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. , 1997, Genes & development.

[9]  K. Johnson,et al.  An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene. , 1996, Immunity.

[10]  B. Wasylyk,et al.  Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. , 1996, Genes & development.

[11]  T. Libermann,et al.  Characterization of NERF, a novel transcription factor related to the Ets factor ELF-1 , 1996, Molecular and cellular biology.

[12]  N. Lenny,et al.  AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. , 1996, Oncogene.

[13]  M. Busslinger,et al.  Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Orkin,et al.  The transcriptional control of hematopoiesis. , 1996, Blood.

[15]  M. Marín‐Padilla,et al.  Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Golub,et al.  The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription , 1996, Molecular and cellular biology.

[17]  D. Tenen,et al.  CCAAT Enhancer-Binding Protein ( C / EBP ) and AML 1 ( CBF a 2 ) Synergistically Activate the Macrophage Colony-Stimulating Factor Receptor Promoter , 1995 .

[18]  J. Downing,et al.  AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.

[19]  J. Zhang,et al.  The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. , 1995, Oncogene.

[20]  S. Shurtleff,et al.  TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. , 1995, Leukemia.

[21]  W. Strober,et al.  BSAP: a key regulator of B-cell development and differentiation. , 1995, Immunology today.

[22]  J. Rowley,et al.  AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. , 1995, Blood.

[23]  D C Ward,et al.  Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R Grosschedl,et al.  Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. , 1995, Genes & development.

[25]  E. Wagner,et al.  Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5 BSAP , 1994, Cell.

[26]  A. Look,et al.  Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1) , 1994, Molecular and cellular biology.

[27]  I. Bar-Am,et al.  AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. , 1994, Genomics.

[28]  S Meyers,et al.  PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells , 1994, Molecular and cellular biology.

[29]  W. Strober,et al.  The murine Ig 3' alpha enhancer is a target site with repressor function for the B cell lineage-specific transcription factor BSAP (NF-HB, S alpha-BP). , 1994, Journal of immunology.

[30]  S. Desiderio,et al.  Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein. , 1994, The Journal of biological chemistry.

[31]  S. Cameron,et al.  Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo footprinting. , 1994, Blood.

[32]  M. Busslinger,et al.  The transcription factor BSAP (NF-HB) is essential for immunoglobulin germ-line epsilon transcription. , 1994, Journal of immunology.

[33]  Y. Yazaki,et al.  Generation of the AML1‐EVI‐1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. , 1994, The EMBO journal.

[34]  M. Krangel,et al.  Regulation of the T-cell receptor delta enhancer by functional cooperation between c-Myb and core-binding factors , 1994, Molecular and cellular biology.

[35]  D. Tenen,et al.  The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor , 1993, Molecular and cellular biology.

[36]  N. Speck,et al.  Cooperative binding of Ets-1 and core binding factor to DNA , 1994, Molecular and cellular biology.

[37]  M. Ohki,et al.  The Runt domain identifies a new family of heteromeric transcriptional regulators. , 1993, Trends in genetics : TIG.

[38]  G. Schaffner,et al.  DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site. , 1993, Genes & development.

[39]  J. Downing,et al.  Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions , 1993, Molecular and cellular biology.

[40]  D. Scott,et al.  Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[41]  F. Collins,et al.  Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. , 1993, Science.

[42]  Y. Ito,et al.  PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Singh,et al.  NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3' alpha enhancer at early stages of B-cell differentiation , 1993, Molecular and cellular biology.

[44]  N. Speck,et al.  Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor , 1993, Molecular and cellular biology.

[45]  N. Speck,et al.  The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-gamma and -delta gene expression. , 1993, Journal of immunology.

[46]  A. Friedman,et al.  The murine myeloperoxidase promoter contains several functional elements, one of which binds a cell type-restricted transcription factor, myeloid nuclear factor 1 (MyNF1) , 1993, Molecular and cellular biology.

[47]  D. Scott,et al.  Expression of Protein Tyrosine Kinases in the Ig Complex of anti‐μ‐Sensitive and anti‐μ‐Resistant B‐Cell Lymphomas: Role of the p55blk Kinase in Signaling Growth Arrest and Apoptosis , 1993, Immunological reviews.

[48]  P. Watkins,et al.  Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells. , 1992, Cancer genetics and cytogenetics.

[49]  D. Mason,et al.  The B29 and mb‐1 polypeptides are differentially expressed during human B cell differentiation , 1992, European journal of immunology.

[50]  H. Drabkin,et al.  Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. , 1992, Blood.

[51]  J. Lin,et al.  The MB-1/B29 heterodimer couples the B cell antigen receptor to multiple src family protein tyrosine kinases. , 1992, Journal of immunology.

[52]  A. Aguzzi,et al.  Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. , 1992, Genes & development.

[53]  M. Busslinger,et al.  The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP , 1992, Molecular and cellular biology.

[54]  F. Calabi,et al.  Leukaemia/Drosophila homology , 1992, Nature.

[55]  K. Zeller,et al.  Structure and developmental regulation of the B-lymphoid tyrosine kinase gene blk. , 1992, The Journal of biological chemistry.

[56]  M. Reth.  Antigen receptors on B lymphocytes. , 1992, Annual review of immunology.

[57]  N. Speck,et al.  Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. , 1992, Molecular and cellular biology.

[58]  M. Ohki,et al.  t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[59]  A. Burkhardt,et al.  Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[60]  A. Barberis,et al.  A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation. , 1990, Genes & development.

[61]  J. Rowley,et al.  Recurring chromosome abnormalities in leukemia and lymphoma. , 1990, Seminars in hematology.

[62]  S. Desiderio,et al.  Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. , 1990, Science.

[63]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.